It's shaping up to be a big year for Boehringer Ingelheim—at least if the FDA plays ball. | Boehringer Chief Medical Officer ...

The data from 2019 to 2023 show rapid uptake of the drugs alongside wide patient- and practice-level variations.

Veeva Systems (NYSE: VEEV) today announced Boehringer Ingelheim is the latest top 20 biopharma to standardize customer data across more than 100 countries with Veeva OpenData and Veeva Network. Accura ...

Investing.com -- Wells Fargo (NYSE: WFC) has initiated coverage of Zealand Pharma (NASDAQ: ZEAL) with an Overweight rating ...

Sen. Tim Kaine has been involved with bringing pharmaceutical reseach and development to central Virginia since his days on ...

Sanofi's wide lineup of branded drugs and vaccines and robust pipeline create strong cash flows and a narrow economic moat. Growth of existing products and new product launches should help offset ...

New research from investigators at Mass General Brigham suggests that a commonly used type 2 diabetes medication is linked to a higher rate of ...

LEO Pharma’s Anzupgo (delgocitinib) cream has been approved by the US Food and Drug Administration (FDA) to treat adults with ...

A recent study reveals only a handful of individuals globally achieve billionaire status before 30, primarily through ...

The Sustainable Control of Parasites in Sheep (SCOPS) group is excited to announce the launch of season 3 of the SCOPS podcast, with episode 1 now available on all major platforms.

Findings published in JAMA Dermatology suggest that the use of immune checkpoint inhibitors may double psoriasis risk for ...